Phase 2 COVID-19 Vaccine Variant Clinical Trial

NIH RePORTER · NIH · N01 · $36,854,858 · view on reporter.nih.gov ↗

Abstract

To support a Phase 2 clinical trial evaluating various additional COVID-19 booster shots, the COVID-19 Variant Immunologic Landscape (COVAIL) clinical trial.

Key facts

NIH application ID: 10683817
Project number: 75N91019D00024-0-759102200007-1
Recipient: LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator: THERESA ENGEL
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $36,854,858
Award type: —
Project period: 2022-03-07 → 2024-03-06